TransVIHMI, Université de Montpellier, IRD, INSERM, Montpellier, France.
TransVIHMI, IRD, INSERM, University of Montpellier, Center Régional de Recherche et de Formation au VIH et Maladies Associées de Fann, Dakar, Senegal.
Front Public Health. 2021 Oct 18;9:653481. doi: 10.3389/fpubh.2021.653481. eCollection 2021.
Since 2019, the ATLAS project, coordinated by Solthis in collaboration with national AIDS programs, has introduced, promoted and delivered HIV self-testing (HIVST) in Côte d'Ivoire, Mali and Senegal. Several delivery channels have been defined, including key populations: men who have sex with men, female sex workers and people who use injectable drugs. At project initiation, a qualitative study analyzing the perceptions and attitudes of key stakeholders regarding the introduction of HIVST in their countries and its integration with other testing strategies for key populations was conducted. The study was conducted from September to November 2019 within 3 months of the initiation of HIVST distribution. Individual interviews were conducted with 60 key informants involved in the project or in providing support and care to key populations: members of health ministries, national AIDS councils, international organizations, national and international non-governmental organizations, and peer educators. Semi structured interviews were recorded, translated when necessary, and transcribed. Data were coded using Dedoose© software for thematic analyses. We found that stakeholders' perceptions and attitudes are favorable to the introduction and integration of HIVST for several reasons. Some of these reasons are held in common, and some are specific to each key population and country. Overall, HIVST is considered able to reduce stigma; preserve anonymity and confidentiality; reach key populations that do not access testing the usual strategies; remove spatial barriers; save time for users and providers; and empower users with autonomy and responsibility. It is non-invasive and easy to use. However, participants also fear, question and doubt users' autonomy regarding their ability to use HIVST kits correctly; to ensure quality secondary distribution; to accept a reactive test result; and to use confirmation testing and care services. For stakeholders, HIVST is considered an attractive strategy to improve access to HIV testing for key populations. Their doubts about users' capacities could be a matter for reflective communication with stakeholders and local adaptation before the implementation of HIVST in new countries. Those perceptions may reflect the West African HIV situation through the emphasis they place on the roles of HIV stigma and disclosure in HIVST efficiency.
自 2019 年以来,ATLAS 项目由 Solthis 协调,与国家艾滋病规划署合作,在科特迪瓦、马里和塞内加尔引入、推广和提供艾滋病毒自检 (HIVST)。已经确定了几个交付渠道,包括重点人群:男男性行为者、性工作者和注射吸毒者。在项目启动时,进行了一项定性研究,分析了利益攸关方对在其国家引入 HIVST 及其与重点人群其他检测策略相结合的看法和态度。该研究于 2019 年 9 月至 11 月在 HIVST 分发启动后 3 个月内进行。对参与项目或向重点人群提供支持和护理的 60 名关键信息提供者进行了个人访谈:卫生部成员、国家艾滋病理事会、国际组织、国家和国际非政府组织以及同伴教育者。对半结构化访谈进行了记录,必要时进行了翻译,并进行了转录。使用 Dedoose©软件对数据进行了编码,以便进行主题分析。我们发现,利益攸关方的看法和态度是有利于引入和整合 HIVST 的,原因有几个。其中一些原因是共同的,而另一些则是针对每个重点人群和国家的。总的来说,HIVST 被认为能够减少污名化;保护匿名性和保密性;接触无法通过常规策略接受检测的重点人群;消除空间障碍;为用户和提供者节省时间;并赋予用户自主权和责任感。它是非侵入性的,易于使用。然而,参与者也担心、质疑和怀疑用户使用 HIVST 试剂盒的能力;确保质量的二次分配;接受反应性检测结果;并使用确认检测和护理服务。对于利益攸关方来说,HIVST 被认为是改善重点人群获得艾滋病毒检测的一项有吸引力的策略。他们对用户能力的怀疑可能是在新国家实施 HIVST 之前与利益攸关方进行反思性沟通和进行地方适应性调整的问题。这些看法可能反映了西非的艾滋病毒情况,强调了艾滋病毒污名和披露在 HIVST 效率中的作用。
South Afr J HIV Med. 2020-7-22
J Int Assoc Provid AIDS Care. 2020
Diagnostics (Basel). 2020-4-1